Mattia Barbareschi
Mattia Barbareschi
S. Chiara Hospital, Trento, Italy
Verified email at apss.tn.it
TitleCited byYear
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
G Gasparini, N Weidner, P Bevilacqua, S Maluta, P Dalla Palma, O Caffo, ...
Journal of Clinical Oncology 12 (3), 454-466, 1994
5491994
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast
M Barbareschi, L Pecciarini, MG Cangi, E Macrž, A Rizzo, G Viale, ...
The American journal of surgical pathology 25 (8), 1054-1060, 2001
4222001
PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.
E Leonardi, S Girlando, G Serio, FA Mauri, G Perrone, S Scampini, ...
Journal of clinical pathology 45 (5), 416-419, 1992
2691992
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
G Gasparini, M Barbareschi, C Doglioni, PD Palma, FA Mauri, P Boracchi, ...
Clinical cancer research 1 (2), 189-198, 1995
2261995
High syndecan‐1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
M Barbareschi, P Maisonneuve, D Aldovini, MG Cangi, L Pecciarini, ...
Cancer: Interdisciplinary International Journal of the American Cancer†…, 2003
2252003
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs
M Barbareschi, B Murer, TV Colby, M Chilosi, E Macri, M Loda, C Doglioni
The American journal of surgical pathology 27 (2), 141-149, 2003
1942003
Prognostic value of p21 (WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.
O Caffo, C Doglioni, S Veronese, M Bonzanini, A Marchetti, F Buttitta, ...
Clinical cancer research 2 (9), 1591-1599, 1996
1771996
AKT1E17K in human solid tumours
FE Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo, ...
Oncogene 27 (42), 5648, 2008
1762008
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas
M Barbareschi, F Buttitta, L Felicioni, S Cotrupi, F Barassi, ...
Clinical Cancer Research 13 (20), 6064-6069, 2007
1762007
p53 and c-erb B-2 Protein Expression in Breast Carcinomas: An Immunohistochemical Study Including Correlations with Receptor Status, Proliferation Markers, and Clinical Stage†…
M Barbareschi, E Leonardi, FA Mauri, G Serio, PD Palma
American journal of clinical pathology 98 (4), 408-418, 1992
1661992
p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.
A Marchetti, C Doglioni, M Barbareschi, F Buttitta, S Pellegrini, G Bertacca, ...
Oncogene 12 (6), 1319-1324, 1996
1651996
The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status
C Doglioni, A Dei Tos, L Laurino, C Chiarelli, M Barbareschi, G Viale
Virchows Archiv 424 (1), 47-51, 1994
1521994
mdm2 gene alterations and mdm2 protein expression in breast carcinomas
A Marchetti, F Buttitta, S Girlando, PD Palma, S Pellegrini, P Fina, ...
The Journal of pathology 175 (1), 31-38, 1995
1411995
Proliferating cell nuclear antigen expression in central nervous system neoplasms
A Allegranza, S Girlando, GL Arrigoni, S Veronese, FA Mauri, ...
Virchows Archiv A 419 (5), 417-423, 1991
1381991
p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene†…
M Barbareschi, O Caffo, C Doglioni, P Fina, A Marchetti, F Buttitta, R Leek, ...
British journal of cancer 74 (2), 208, 1996
1361996
Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine‐needle aspiration cytology: a retrospective study of 103 cases with surgical correlation
L Righi, P Graziano, A Fornari, G Rossi, M Barbareschi, A Cavazza, ...
Cancer 117 (15), 3416-3423, 2011
1342011
Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up
M Barbareschi, O Caffo, S Veronese, RD Leek, P Fina, S Fox, ...
Human pathology 27 (11), 1149-1155, 1996
1281996
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
M Cigognetti, S Lonardi, S Fisogni, P Balzarini, V Pellegrini, A Tironi, ...
Modern Pathology 28 (8), 1043, 2015
1262015
p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation
C Doglioni, P Pelosio, L Laurino, E Macri, E Meggiolaro, F Favretti, ...
The Journal of pathology 179 (3), 248-253, 1996
1221996
Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size
S Rossi, D Gasparotto, L Toffolatti, C Pastrello, G Gallina, A Marzotto, ...
The American journal of surgical pathology 34 (10), 1480-1491, 2010
1212010
The system can't perform the operation now. Try again later.
Articles 1–20